{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:30:58Z","timestamp":1755599458900},"reference-count":17,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej20-0099","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T22:05:21Z","timestamp":1590703521000},"page":"929-934","source":"Crossref","is-referenced-by-count":3,"title":["First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans"],"prefix":"10.1507","volume":"67","author":[{"given":"Jacopo","family":"Manso","sequence":"first","affiliation":[{"name":"Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Censi","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[{"name":"Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), Endocrine Surgery Unit, Padua University Hospital, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Galuppini","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), Surgical Pathology and Cytopathology Unit, Padua University, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmaria","family":"Pennelli","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), Surgical Pathology and Cytopathology Unit, Padua University, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Betterle","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, et al. (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 275: 104\u2013115.","DOI":"10.1111\/joim.12162"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23: 327\u2013364.","DOI":"10.1210\/edrv.23.3.0466"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison\u2019s disease in adults. J Endocrinol Invest 42: 1407\u20131433.","DOI":"10.1007\/s40618-019-01079-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Manso J, Pezzani R, Scarpa R, Gallo N, Betterle C (2018) The natural history of autoimmune Addison\u2019s disease with a non-classical presentation: a case report and review of literature. Clin Chem Lab Med 56: 896\u2013900.","DOI":"10.1515\/cclm-2017-1108"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Neufeld M, Maclaren NK, Blizzard RM (1981) Two types of autoimmune Addison\u2019s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60: 355\u2013362.","DOI":"10.1097\/00005792-198109000-00003"},{"key":"6","unstructured":"6 Betterle C, Volpato M, Pedini B, Chen S, Smith BR, et al. (1999) Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison\u2019s disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 84: 618\u2013622."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658\u20135671.","DOI":"10.1210\/jcem.86.12.8070"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Wells SA, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab 98: 3149\u20133164.","DOI":"10.1210\/jc.2013-1204"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, et al. (2015) Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid 25: 567\u2013610.","DOI":"10.1089\/thy.2014.0335"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Thakker RV (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386: 2\u201315.","DOI":"10.1016\/j.mce.2013.08.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Tuttle RM, Haugen B, Perrier ND (2017) Updated American joint committee on cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (Eighth Edition): what changed and why? Thyroid 27: 751\u2013756.","DOI":"10.1089\/thy.2017.0102"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Bahl VK, Sandhu A, Mohan V, Nolan S (1998) Multiple endocrine neoplasia and polyglandular autoimmune syndrome: a new association. Endocr Pract 4: 208\u2013212.","DOI":"10.4158\/EP.4.4.208"},{"key":"13","unstructured":"13 Toni Garc\u00eda M, Anda Api\u00f1\u00e1niz E, Pablo J, de Esteban M, Mun\u00e1rriz Alcuaz P, et al. (2008) An unusual association: pheochromocytoma on an atrophied adrenal gland due to addison\u2019s disease. Endocrinol Nutr 55: 510\u2013513."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Arias EAS, Castillo VA, Trigo RH (2018) Addison disease and normocalcemic primary hyperparathyroidism in a dog with multiple endocrine neoplasia. Open Vet J 7: 332\u2013336.","DOI":"10.4314\/ovj.v7i4.8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Arias EAS, Castillo VA, Trigo RH, Caneda Aristarain ME (2016) Multiple endocrine neoplasia similar to human subtype 2A in a dog: medullary thyroid carcinoma, bilateral pheochromocytoma and parathyroid adenoma. Open Vet J 6: 165\u2013171.","DOI":"10.4314\/ovj.v6i3.4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Wright KN, Breitschwerdt EB, Feldman JM, Berry CR, Meuten DJ, et al. (1995) Diagnostic and therapeutic considerations in a hypercalcemic dog with multiple endocrine neoplasia. J Am Anim Hosp Assoc 31: 156\u2013162.","DOI":"10.5326\/15473317-31-2-156"},{"key":"17","unstructured":"17 Peterson ME, Randolph JF, Zaki FA, Heath H 3rd (1982) Multiple endocrine neoplasia in a dog. J Am Vet Med Assoc 180: 1476\u20131478."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/9\/67_EJ20-0099\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:35:25Z","timestamp":1601696125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/9\/67_EJ20-0099\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0099","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}